Primary record
1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-, (2R-trans)-
- 库存
- 1,749 克
- 纯度
- 98.3 %
- CAS
- 163217-74-1
化合物标识与属性
- CAS
- 163217-74-1
- PubChem CID
- 10650434
- SMILES
- CC(C)C1=C(C(=C(N1CC[C@@H]2C[C@H](CC(=O)O2)O)C3=CC=C(C=C3)F)C4=CC=CC=C4)C(=O)NC5=CC=CC=C5O
- Canonical SMILES
- CC(C)c1c(C(=O)Nc2ccccc2O)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H]1C[C@@H](O)CC(=O)O1
名称与同义词
- 2-Hydroxy Atorvastatin Lactone
- 163217-74-1
- O-HYDROXYATORVASTATIN LACTONE
- O-Hydroxy atorvastatin lactone
- Orthohydroxyatorvastatin lactone
- UNII-N8OH05250C
- RefChem:167222
- Atorvastatin Impurity 93
- Ortho-Hydroxy Atorvastatin Lactone
- Atorvastatin 2-Hydroxy Lactone
- N8OH05250C
- DTXSID50167536
- orb1692177
- SCHEMBL5605044
- DTXCID2090027
- ortho-Hydroxyatorvastatin lactone
- C33H33FN2O5
- CTK8E9695
- CHEBI:183888
- 2-Hydroxy Atorvastatin Lactone-d5
- ZINC3932205
- 2-Hydroxy Atorvastatin Lactone(EP)
- EX-A10871
- MFCD00936960
- AKOS030241919
- CS-O-14406
- FH23908
- CID10650434
- CID 10816722
- HY-136346
- RT-007822
- CS-0128382
- NS00078029
- 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-
- J1.137.567G
- G12902
- 5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N-(2-hydroxyphenyl)-4-phenyl-2-propan-2-ylpyrrole-3-carboxamide
- A1013761
- Q27284712
- (2R-Trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N-(2-hydroxyphenyl)-4-phenyl-1-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1H-pyrrole-3-carboxamide
- 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-
- 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-, (2R-trans)-
- 5-(4-Fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)-ethyl)-N-(2-hydroxyphenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamide
- 5-(4-fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-N-(2-hydroxyphenyl)-4-phenyl-2-(propan-2-yl)-1H-pyrrole-3-carboxamide
- 5-(4-Fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide
- (3R,5R)-3,5-Dihydroxy-7-[2-(1-methylethyl)-3-[(2-hydroxyphenylamino)carbonyl]-4-phenyl-5-(4-fluorophenyl)-1H-pyrrole-1-yl]heptanoic acid 1,5-lactone
- 1H-Pyrrole-3-carboxamide,5-(4-fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-
- 5-(4-fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-N-(2-hydroxyphenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamide
- 5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-N-(2-hydroxyphenyl)-2-isopropyl-4-phenyl-pyrrole-3-carboxamide
- 5-(4-fluorophenyl)-1-{2-[(2r,4r)-4-hydroxy-6-oxotetrahydro-2h-pyran-2-yl]ethyl}-n-(2-hydroxyphenyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxamide
- 5-(4-Fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-p yrrole-3-carboxamide
- 5-(4-luorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N-(2-hydroxyphenyl)-4-phenyl-2-propan-2-ylpyrrole-3-carboxamide